PCCNC logo

Public Awareness 
NC Statistics 
Community Programs 
Prostate Function 
Prostate Cancer 
Other Conditions 
Risk Reduction 
Disparities 

Early Detection 
About Screening 
Prostate Cancer Symptoms 
Screening Follow-Up 
Diagnosing Cancer 

Prostate Screening 
Practice Guidelines 
Coordinator Resources 
Screening Events 

Patient Tools 
Information Resources 
Newly Diagnosed 
Support Groups 
Caregivers 
Cancer Centers 
Financial Programs 
Clinical Trials 
Treatment 

Advocate Tools 
Presentations 
Handouts 

 
Home | About PCCNC | Programs | Annual Events | Legislation | News | Membership

The Prostate Specific Antigen (PSA) Blood Test

print friendly version of this page |

Recent findings emphasis the importance of PSA velocity or "annual rate of change" CLICK HERE to print a PSA Tracker.

PSA or Prostate Specific Antigen is a protein originating from the prostate that can be detected in blood. PSA testing detects elevated PSA levels. Elevated or rising PSA levels are used as a signal that there is something wrong with the prostate.

 Lee County Prostate Cancer Support Group's Relay for Life psa screening (sponsored by Pfizer)

"The PSA test can be compared to the Pap smear controversy years ago,...There was never a randomized study to determine whether or not the Pap smear reduced death rates from cervical cancer. But death rates dropped dramatically once the Pap smear became available. We appear to be approaching the same point now with the PSA test."

-Judd W. Moul, MD, FACS, Chief, Director Duke Prostate Center

The 2006 National Comprehensive Cancer Network (NCCN) guidelines (PDF) point out that the PSA threshold of 4.0 ng/mL will miss a significant number of potentially curable tumors. Recent studies of the incidence of cancer in men whose PSA is in the range of 2.5 to 4.0 ng/mL have shown that a substantial number of men in this group will have prostate cancer. 2004 NCCN guidelines reference a study of 332 screened men with PSA in this range, in which 22% of them were found to have prostate cancer. Experts estimate that lowering the PSA threshold to 2.5 ng/mL would significantly increase the rate of detecting cancer in men younger than 60 years old with little loss of specificity. At this lower threshold, some studies have shown that the cPSA test can be more predictive of prostate cancer and can result in fewer false diagnoses and unnecessary biopsies compared to the PSA test.

Additional studies continue to show the importance of PSA velocity (annual rate of change).

To read PDF files, you will need a copy of Adobe Acrobat Reader.
Click here to download a copy:

A study published in the Urology Times, describes how researchers are finding that normal PSA ranges vary with both race and age. Joseph E. Oesterling, director of the Michigan Prostate Institute and urologist-in-chief at the Medical Center, devised a breakdown showing the upper limit of normal PSA levels for a variety of age and race combinations (see below).

age and race adjusting PSA

PSA levels can also be increased shortly after bicycling, within 24 hours from an ejaculation, when there is a presence of high rheumatic factors in the blood and after a DRE or a biopsy. When scheduling a PSA or planning to attend a free screening these factors should be taken into account or avoided.

copyright notice

disclaimer

Prostate Cancer Coalition of North Carolina (PCCNC)
5905 Shamrock Road
Research Triangle Park, NC 27713
919.321.0365
email

About PCCNC
Awareness | Prostate Cancer 101 | Risk Factors | Prevention | Statistics
Early Detection | Prostate Screening | The PSA Blood Test | The Digital Exam (DRE)
NC Insurance Statutes | Screening Locations | Referral Guidelines | Diagnostic Tools
Patient Resources | Understanding Diagnosis | Support Groups | Cancer Centers | Clinical Trials | Treatment
Advocate Tools | Presentations | Handouts | Gift Items
Volunteer | Donate | In the News | Calendar | Legislative Advocacy
Medical Professionals | Minority Communities | Partners & Caregivers